-
$65.00
AOD9604 is a modified derivative of the human growth hormone (hGH) fragment 176-191 peptide, featuring a di-sulfide bridge that enhances its stability. Originally developed for its lipolytic (fat-burning) properties, AOD9604 has also demonstrated potential benefits in research related to heart disease, osteoarthritis and cartilage repair, as well as metabolic syndrome. Animal studies indicate that AOD9604 promotes lipolysis—the breakdown of fat—while simultaneously inhibiting lipogenesis, the process of fat formation.
-
$46.00
Ipamorelin is a short peptide sequence that selectively binds to the ghrelin/growth hormone secretagogue receptor. It is recognized as one of the most selective growth hormone (GH) secretagogues, showing no effect on the release of ACTH, prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), or cortisol in laboratory studies [1]. Due to its high specificity, ipamorelin has garnered interest both as a therapeutic agent and as a model peptide for investigating the mechanisms behind selective GH receptor binding. It plays a crucial role in the growth and repair of musculoskeletal tissues.
-
$55.00
KPV is an anti-inflammatory peptide that has demonstrated potential in various disease models. It has been most extensively studied in the context of inflammatory bowel disease, where it has shown encouraging results in reducing inflammation. Research also indicates that KPV and other alpha-MSH derivatives may support wound healing by helping to control inflammation, lower the risk of infection, and improve healing outcomes, including cosmetic appearance. These peptides are being investigated for their possible applications in wound care and scar management, particularly following surgical procedures.
